XML 35 R22.htm IDEA: XBRL DOCUMENT v3.22.4
Employee Benefit Plans
12 Months Ended
Dec. 31, 2022
Employee Benefit Plans  
Employee Benefit Plans

14.  Employee Benefit Plans

Stock Option Plans

The Company has maintained option plans and maintains an equity incentive plan, which allow for the grant of options to officers, employees and members of the Board of Directors. Grants of options under the Company’s plans generally vest over 3 years and must be exercised within 10 years of the date of grant. Transactions under the Company’s stock option plans for 2022, 2021 and 2020 are summarized in the following table:

    

    

    

Weighted

    

Weighted 

average

average 

remaining

Aggregate

exercise

contractual 

intrinsic

Shares

price

life in years

value

Outstanding at December 31, 2019

 

614,311

$

14.78

 

6.9

$

4,783,402

Options granted

 

151,500

 

19.80

 

  

 

  

Options exercised

 

(63,011)

 

7.16

 

  

 

  

Options forfeited

 

(30,000)

 

19.50

 

  

 

  

Options expired

 

 

 

  

 

  

Outstanding at December 31, 2020

 

672,800

$

16.42

 

6.8

$

1,952,568

Options granted

 

89,000

 

19.21

 

 

Options exercised

 

(71,267)

 

8.84

 

 

Options forfeited

 

(2,000)

 

18.64

 

 

Options expired

 

 

 

 

Outstanding at December 31, 2021

 

688,533

$

17.56

 

6.6

$

5,986,666

Options granted

 

 

 

 

Options exercised

 

(115,538)

 

14.70

 

 

Options forfeited

 

(13,496)

 

19.75

 

 

Options expired

 

 

 

 

Outstanding at December 31, 2022

 

559,499

$

18.09

 

5.9

$

5,168,740

Exercisable at December 31, 2022

455,014

$

17.76

 

5.5

$

4,353,237

On April 25, 2019, the Company adopted the 2019 Equity Compensation Plan providing for grants of up to 500,000 shares to be allocated between incentive and non-qualified stock options, restricted stock awards, performance units and deferred stock. The Plan replaced all previously approved and established equity plans then currently in effect. As of December 31, 2022, 281,500 options and 209,400 shares of restricted stock have been awarded from the plan. In addition, 15,496 unvested options and 12,400 unvested shares of restricted stock were cancelled and returned to the plan leaving 36,996 shares available for future grants.

The fair values of the options granted during 2021 and 2020 were estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions. There were no options granted during 2022.

For the years ended December 31, 

 

    

2022

    

2021

    

2020

 

Number of options granted

 

 

89,000

 

151,500

Weighted average exercise price

$

$

19.21

$

19.80

Weighted average fair value of options

$

$

7.72

$

6.12

Expected life in years (1)

 

 

8.38

 

8.50

Expected volatility (2)

 

%  

 

43.69

%  

 

32.69

%

Risk-free interest rate (3)

 

%  

 

1.14

%  

 

1.28

%

Dividend yield (4)

 

%  

 

1.68

%  

 

1.64

%

(1)The expected life of the options was estimated based on historical employee behavior and represents the period of time that options granted are expected to be outstanding.
(2)The expected volatility of the Company’s stock price was based on the historical volatility over the period commensurate with the expected life of the options.
(3)The risk-free interest rate is the U.S. Treasury rate commensurate with the expected life of the options on the date of grant.
(4)The expected dividend yield is the projected annual yield based on the grant date stock price.

Upon exercise, the Company issues shares from its authorized but unissued common stock to satisfy the options. The following table presents information about options exercised during 2022, 2021 and 2020:

For the years ended December 31, 

    

2022

    

2021

    

2020

Number of options exercised

 

115,538

 

71,267

 

63,011

Total intrinsic value of options exercised

$

1,614,421

$

974,776

$

564,314

Cash received from options exercised

1,698,357

630,302

451,420

Tax deduction realized from options

485,698

293,261

169,774

The following table summarizes information about stock options outstanding and exercisable at December 31, 2022:

Options outstanding

Options exercisable

    

Weighted average 

    

Weighted 

    

    

Weighted

Options

remaining contractual 

average 

Options

average

Range of exercise prices

outstanding

life (in years)

exercise price

exercisable

exercise price

$7.25 - $16.51

 

140,533

 

4.0

$

11.93

 

128,867

$

11.54

$16.52 - $19.26

 

135,166

 

6.8

18.08

 

97,013

18.16

$19.27 - $20.88

 

143,500

 

6.5

20.30

 

110,834

20.22

$20.89 - $22.57

 

140,300

 

6.4

22.02

 

118,300

21.92

Total

 

559,499

 

5.9

$

18.09

 

455,014

$

17.76

FASB ASC Topic 718, “Compensation - Stock Compensation,” requires an entity to recognize the fair value of equity awards as compensation expense over the period during which an employee is required to provide service in exchange for such an award (vesting period). Compensation expense related to stock options and the related income tax benefit for the years ended December 31, 2022, 2021 and 2020 are detailed in the following table:

For the years ended December 31,

    

2022

    

2021

    

2020

Compensation expense

$

567

$

867

$

744

Income tax benefit

164

251

215

As of December 31, 2022, unrecognized compensation costs related to nonvested share-based compensation arrangements granted under the Company’s stock option plans totaled approximately $350 thousand. That cost is expected to be recognized over a weighted average period of 1.1 years.

Restricted Stock Awards

Restricted stock is issued under the 2019 Equity Compensation Plan to reward employees and directors and to retain them by distributing stock over a period of time. Restricted stock awards granted to date vest over a period of 4 years and are recognized as compensation to the recipient over the vesting period. The awards are recorded at fair market value at the time of grant and amortized into salary expense on a straight line basis over the vesting period. The following table summarizes nonvested restricted stock activity for the year ended December 31, 2022:

    

    

Average grant

Shares

date fair value

Nonvested restricted stock at December 31, 2021

 

119,487

$

21.00

Granted

 

97,700

 

27.48

Cancelled

 

(11,587)

 

23.29

Vested

 

(41,030)

 

20.68

Nonvested restricted stock at December 31, 2022

 

164,570

$

24.77

Restricted stock awards granted during the years ended December 31, 2022, 2021 and 2020 were as follows:

For the years ended December 31,

    

2022

    

2021

    

2020

Number of shares granted

 

97,700

 

68,550

 

27,250

Average grant date fair value

$

27.48

$

22.15

$

17.12

Compensation expense related to the restricted stock for the years ended December 31, 2022, 2021 and 2020 is detailed in the following table:

For the years ended December 31, 

    

2022

    

2021

    

2020

Compensation expense

$

1,114

$

750

$

667

Income tax benefit

$

320

$

217

$

193

As of December 31, 2022, there was approximately $3.3 million of unrecognized compensation cost related to nonvested restricted stock awards granted under the Company’s stock incentive plans. That cost is expected to be recognized over a weighted average period of 3.0 years.

401(k) Savings Plan

The Bank has a 401(k) savings plan covering substantially all employees. Under the Plan, an employee can contribute up to 75 percent of their salary on a tax deferred basis. The Bank may also make discretionary contributions to the Plan. The Bank contributed $790 thousand, $786 thousand, and $675 thousand to the Plan in 2022, 2021 and 2020, respectively.

Deferred Fee Plan

The Company has a deferred fee plan for Directors and eligible management. Directors of the Company have the option to elect to defer up to 100 percent of their respective retainer and Board of Director fees, and each eligible member of management has the option to elect to defer 100 percent of their total compensation. Director and executive deferred compensation totaled $674 thousand in 2022, $593 thousand in 2021 and $591 thousand in 2020, and the interest paid on deferred balances totaled $162 thousand in 2022, $136 thousand in 2021 and $132 thousand in 2020. The deferred balances distributed totaled $14 thousand in 2022, 2021 and 2020.

Benefit Plans

In addition to the 401(k) savings plan which covers substantially all employees, in 2015 the Company established an unfunded supplemental defined benefit plan to provide additional retirement benefits for the President and Chief Executive Officer (“CEO”) and unfunded, non-qualified deferred retirement plans for certain other key executives.

On June 4, 2015, the Company approved the Supplemental Executive Retirement Plan (“SERP”) pursuant to which the President and CEO is entitled to receive certain supplemental nonqualified retirement benefits. The retirement benefit under the SERP is an amount equal to sixty percent (60%) of the average of the President and CEO’s base salary for the thirty-six (36) months immediately preceding the executive’s separation from service after age 66, adjusted annually thereafter by a percentage equal to the Consumer Price Index as reported by the U.S. Bureau of Labor Statistics for All Urban Consumers (CPI-U). The total benefit is to be made payable in fifteen annual installments. The future payments are estimated to total $7.2 million. A discount rate of four percent (4%) was used to calculate the present value of the benefit obligation.

The President and CEO commenced vesting to this retirement benefit on January 1, 2014, and it will vest an additional three percent (3%) each year until fully vested on January 1, 2024. In the event that the President and CEO’s separation from service from the Company were to occur prior to full vesting, the President and CEO would be entitled to and shall be paid the vested portion of the retirement benefit calculated as of the date of separation from service. Notwithstanding the foregoing, upon a Change in Control, and provided that within 6 months following the Change in Control the President and CEO is involuntarily terminated for reasons other than “cause” or the President and CEO resigns for “good reason”, as such is defined in the SERP, or the President and CEO voluntarily terminates his employment after being offered continued employment in a position that is not a “Comparable Position”, as such is also defined in the SERP, the President and CEO shall become one hundred percent (100%) vested in the full retirement benefit.

No contributions or payments have been made for the year 2022, 2021 or 2020. The following table summarizes the components of the net periodic pension cost of the defined benefit plan recognized during the years ended December 31, 2022, 2021 and 2020:

For the years ended December 31, 

(In thousands)

    

2022

    

2021

    

2020

Service cost

$

150

$

515

$

126

Interest cost

 

186

 

161

 

147

Amortization of prior service cost

 

 

332

 

83

Net periodic benefit cost

$

336

$

1,008

$

356

The following table summarizes the changes in benefit obligations of the defined benefit plan recognized during the years ended December 31, 2022, 2021 and 2020

For the years ended December 31, 

(In thousands)

    

2022

    

2021

    

2020

Benefit obligation, beginning of year

$

4,521

$

3,845

$

3,572

Service cost

 

150

 

515

 

126

Interest cost

 

186

 

161

 

147

Benefit obligation, end of period

$

4,857

$

4,521

$

3,845

On October 22, 2015, the Company entered into an Executive Incentive Retirement Plan (the “Plan”) with key executive officers other than the President and CEO. The Plan has an effective date of January 1, 2015.

The Plan is an unfunded, nonqualified deferred compensation plan. For any Plan Year, a guaranteed annual Deferral Award percentage of seven and one half percent (7.5%) of the participant’s annual base salary shall be credited to each Participant’s Deferred Benefit Account. A discretionary annual Deferral Award equal to seven and one half percent (7.5%) of the participant’s annual base salary may be credited to the Participant’s account in addition to the guaranteed Deferral Award, if the Bank exceeds the benchmarks set forth in the Annual Executive Bonus Matrix. The total Deferral Award shall never exceed fifteen percent (15%) of the participant’s base salary for any given Plan Year. Each Participant shall be one hundred percent (100%) vested in all Deferral Awards as of the date they are awarded.

As of December 31, 2022, the Company had total expenses related to the Plan of $142 thousand, compared to $108 thousand in 2021 and $86 thousand in 2020. The Plan is reflected on the Company’s balance sheet as accrued expenses.

Certain members of management are also enrolled in a split-dollar life insurance plan with a post retirement death

benefit of $250 thousand. Total expenses related to this plan were $22 thousand in 2022 and $5 thousand in 2021 and 2020, respectively. Additionally, $55 thousand of prior period expense was reversed during 2022. This was related to adjustments made to the members of management participating in the plan.